Updated Jul 16, 2026
Galbraith Kenneth is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $3.34M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-13 | ZYME | Zymeworks Inc. | S — Open-market sale | 30.4K | $22.67 | $690K |
| 2026-01-13 | ZYME | Zymeworks Inc. | M — Option exercise | 64.0K | $0.00 | |
| 2026-01-06 | ZYME | Zymeworks Inc. | S — Open-market sale | 31.7K | $25.10 | $795K |
| 2026-01-06 | ZYME | Zymeworks Inc. | M — Option exercise | 66.7K | $0.00 | |
| 2026-01-06 | ZYME | Zymeworks Inc. | S — Open-market sale | 22.7K | $25.10 | $569K |
| 2026-01-06 | ZYME | Zymeworks Inc. | M — Option exercise | 47.7K | $0.00 | |
| 2025-12-22 | ZYME | Zymeworks Inc. | S — Open-market sale | 47.5K | $27.02 | $1.28M |
| 2025-12-22 | ZYME | Zymeworks Inc. | M — Option exercise | 100.0K | $0.00 |
Galbraith Kenneth is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($3.34M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Galbraith Kenneth profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.